ZURICH U.S. drugmaker AbbVie's $63 billion tie-up with Allergan is getting help from Nestle and AstraZeneca buying up products the Irish-domiciled company is shedding to placate regulators.
ZURICH Sickle cell disease drugs made by Novartis and Global Blood Therapeutics (GBT) may not be cost effective at current prices, a draft report published on Friday suggested, widening the debate over U.S. healthcare affordability.
ZURICH, Jan 24 Sickle cell disease drugs made by
Novartis and Global Blood Therapeutics (GBT)
may not be cost effective at current prices, a draft report
published on Friday suggested, widening the debate over U.S.
BEIJING/ZURICH Roche said on Wednesday China had approved the import of its Kadcyla drug for breast cancer, another win for the Swiss drugmaker in its second-biggest market where rising demand has helped drive its increased sales and profit.
FRANKFURT/ZURICH Clariant is reviving the sale of its pigments unit, people familiar with the matter told Reuters, which may fetch up to 900 million Swiss francs ($927.7 million) as the Swiss chemicals maker slims down after failing to combine with peers.
ZURICH Lonza aims to hire a drug industry veteran by late May as chief executive, Chairman Albert Baehny said on Tuesday, as the Swiss company sharpens its focus on its fast-growing pharmaceuticals business and off its slumping chemicals unit.
ZURICH Novartis and Britain's National Health Service (NHS) on Monday announced a pact that will clear the way for accelerated review by the country's health watchdog NICE for heart drug inclisiran, which could make it broadly available as soon as 2021.
ZURICH Swiss biotech group Idorsia on Friday lifted the lid off a 2019 deal for its investigational epilepsy medicine, revealing the pact that is potentially worth more than $400 million is with U.S.-based Neurocrine Biosciences.